Next week, from April 7-9th, we'll be attending DealMAX in Las Vegas, one of the leading events for investment and M&A professionals. Hosted by ACG (the Association for Corporate Growth), this influential dealmaking conference will bring together over 3,000 professionals, representing nearly one-third of all US private equity deals and over $400B in investable capital.
We’re excited to strengthen our connections with US PE houses, Angel Partners, and institutional investors, and we’d love to catch up while we’re there.
If you're attending DealMAX, let’s connect! Send us a message or reach out during the event.
Recent Articles

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

Can The Ghost of CGT Past Forecast What's to Come?
Can the Ghost of CGT Past Forecast What's to Come? In our capacity as M&A advisors, we’re often asked what we think will happen to Capital Gains Tax next month (unfortunately, despite all our combined expertise we can’t fully demystify this one). However, a plotted history of CGT since its inception in 1965, not only reveals how different governments have viewed capital wealth generation, it also signals what might just come next......

Introducing Dr Tom McColm
Morphose is delighted to welcome Dr. Tom McColm as an advisor, bringing a powerful mix of academic excellence and commercial expertise in cleantech and deep-tech ventures. His proven track record in developing and scaling innovative technologies will strengthen Morphose’s advisory capabilities in critical infrastructure and defence.





